TrialJournal of clinical oncology : official journal of the American Society of Clinical Oncology2014

Phase II study of the safety and antitumor activity of the hypoxia-activated prodrug TH-302 in combination with doxorubicin in patients with advanced soft tissue sarcoma.

Sant P Chawla et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.